Skip to main content
eScholarship
Open Access Publications from the University of California

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

  • Author(s): Lee, Byoung Dae
  • Shin, Joo-Ho
  • VanKampen, Jackalina
  • Petrucelli, Leonard
  • West, Andrew B
  • Ko, Han Seok
  • Lee, Yun-Il
  • Maguire-Zeiss, Kathleen A
  • Bowers, William J
  • Federoff, Howard J
  • Dawson, Valina L
  • Dawson, Ted M
  • et al.

Published Web Location

https://doi.org/10.1038/nm.2199
Abstract

Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View